Eric Easom - 03 Nov 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
03 Nov 2022
Transactions value $
-$558,274
Form type
4
Filing time
07 Nov 2022, 19:19:13 UTC
Previous filing
02 Nov 2022
Next filing
09 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$174K -11.1K -27.63% $15.67 29K 03 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$49.4K -3.08K -10.62% $16.02 25.9K 03 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$139K -8.83K -34.04% $15.80 17.1K 04 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$162K -10.2K -59.42% $15.90 6.94K 07 Nov 2022 Direct F1
transaction ANTX Common Stock Sale -$34K -2.04K -29.32% $16.72 4.91K 07 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.